{"id":"NCT02252042","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)","officialTitle":"A Phase III Randomized Trial of MK-3475 (Pembrolizumab) Versus Standard Treatment in Subjects With Recurrent or Metastatic Head and Neck Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-17","primaryCompletion":"2017-05-15","completion":"2022-08-15","firstPosted":"2014-09-29","resultsPosted":"2018-08-13","lastUpdate":"2023-07-17"},"enrollment":495,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Head and Neck Squamous Cell Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Pembrolizumab","otherNames":["MK-3475","KEYTRUDA®"]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"DRUG","name":"Docetaxel","otherNames":[]},{"type":"BIOLOGICAL","name":"Cetuximab","otherNames":[]}],"arms":[{"label":"Pembroliziumab","type":"EXPERIMENTAL"},{"label":"Standard Treatment","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study of pembrolizumab (MK-3475, KEYTRUDA®) versus standard treatment (methotrexate, docetaxel or cetuximab) for the treatment of recurrent or metastatic head and neck squamous cell cancer (HNSCC). Participants will be randomly assigned to receive either pembrolizumab or Investigator's choice of standard treatment. The primary study hypothesis is that pembrolizumab treatment prolongs Overall Survival (OS) when compared to standard treatment.","primaryOutcome":{"measure":"Initial Overall Survival (OS) for All Participants","timeFrame":"Up to approximately 2 years","effectByArm":[{"arm":"Pembrolizumab","deltaMin":8.4,"sd":null},{"arm":"Standard Treatment","deltaMin":7.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.03160"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":17},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["33371020","33239737","30944020","30509740","25979390"],"seeAlso":["https://www.merckclinicaltrials.com/"]},"adverseEventsSummary":{"seriousAny":{"events":110,"n":246},"commonTop":["Anaemia","Fatigue","Asthenia","Constipation","Nausea"]}}